Literature DB >> 24357196

A description of spina bifida cases and co-occurring malformations, 1976-2011.

Samantha E Parker1, Mahsa M Yazdy, Allen A Mitchell, Laurie A Demmer, Martha M Werler.   

Abstract

Mandatory folic acid fortification in the United States corresponded with a decline in the prevalence of spina bifida (SB). The aim of this study was to describe the epidemiologic characteristics of isolated versus non-isolated SB cases in both pre- and post-fortification periods. SB cases in the Slone Epidemiology Center Birth Defects Study from 1976 to 2011 without chromosomal anomalies and syndromes were included. A maternal interview, conducted within 6 months of delivery, collected information on demographics, reproductive history, diet, and supplement use. Daily folic acid intake in the periconceptional period was calculated using both dietary and supplement information and categorized as low intake (<400 µg/day) or high intake (≥400 µg/day). SB cases (n = 1170) were classified as isolated (80.4%) or non-isolated (19.1%). Non-isolated cases were further divided into subgroups based on accompanying major malformations (midline, renal, genital, heart, laterality). Compared to non-isolated cases, isolated cases were more likely to be white, non-Hispanic and have more than 12 years of education. Cases in the renal, genital, and heart subgroups had the lowest proportions of mothers with a high folic acid intake. The change from pre- to post-fortification was associated with a decrease in the proportion of isolated cases from 83% to 72%, though in both periods isolated cases were more likely to be female and their mothers were more likely to have high folic acid intake. These findings highlight the importance of separating isolated and non-isolated cases in etiologic research of SB.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  congenital abnormalities; folic acid; spina bifida

Mesh:

Year:  2013        PMID: 24357196      PMCID: PMC4353584          DOI: 10.1002/ajmg.a.36324

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  38 in total

1.  Spina bifida subtypes and sub-phenotypes by maternal race/ethnicity in the National Birth Defects Prevention Study.

Authors:  A J Agopian; Mark A Canfield; Richard S Olney; Philip J Lupo; Tunu Ramadhani; Laura E Mitchell; Gary M Shaw; Cynthia A Moore
Journal:  Am J Med Genet A       Date:  2011-12-02       Impact factor: 2.802

2.  Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States.

Authors:  Laura J Williams; Cara T Mai; Larry D Edmonds; Gary M Shaw; Russell S Kirby; Charlotte A Hobbs; Lowell E Sever; Lisa A Miller; F John Meaney; Miriam Levitt
Journal:  Teratology       Date:  2002-07

3.  Improved survival among children with spina bifida in the United States.

Authors:  Mikyong Shin; James E Kucik; Csaba Siffel; Chengxing Lu; Gary M Shaw; Mark A Canfield; Adolfo Correa
Journal:  J Pediatr       Date:  2012-06-23       Impact factor: 4.406

4.  Maternal tea consumption during early pregnancy and the risk of spina bifida.

Authors:  Mahsa M Yazdy; Sarah C Tinker; Allen A Mitchell; Laurie A Demmer; Martha M Werler
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-05-29

5.  Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006.

Authors:  Samantha E Parker; Cara T Mai; Mark A Canfield; Russel Rickard; Ying Wang; Robert E Meyer; Patrick Anderson; Craig A Mason; Julianne S Collins; Russell S Kirby; Adolfo Correa
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-09-28

Review 6.  Pregnancy termination following prenatal diagnosis of anencephaly or spina bifida: a systematic review of the literature.

Authors:  Candice Y Johnson; Margaret A Honein; W Dana Flanders; Penelope P Howards; Godfrey P Oakley; Sonja A Rasmussen
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-10-25

7.  Long term maintenance of neural tube defects prevention in a high prevalence state.

Authors:  Julianne S Collins; Kristy K Atkinson; Jane H Dean; Robert G Best; Roger E Stevenson
Journal:  J Pediatr       Date:  2011-02-23       Impact factor: 4.406

8.  Cognitive and functional outcome in spina bifida-Chiari II malformation.

Authors:  Michael D Jenkinson; Sophie Campbell; Caroline Hayhurst; Simon Clark; Jothy Kandasamy; Maggie K Lee; Ann Flynn; Peter Murphy; Conor L Mallucci
Journal:  Childs Nerv Syst       Date:  2010-12-31       Impact factor: 1.475

9.  Decline in prevalence of neural tube defects in a high-risk region of the United States.

Authors:  R E Stevenson; W P Allen; G S Pai; R Best; L H Seaver; J Dean; S Thompson
Journal:  Pediatrics       Date:  2000-10       Impact factor: 7.124

10.  Maternal obesity and risk for birth defects.

Authors:  Margaret L Watkins; Sonja A Rasmussen; Margaret A Honein; Lorenzo D Botto; Cynthia A Moore
Journal:  Pediatrics       Date:  2003-05       Impact factor: 7.124

View more
  4 in total

Review 1.  Early Vs. Expectant Management of Spina Bifida Patients-Are We All Talking About a Risk Stratified Approach?

Authors:  Angelena B Edwards; Micah Jacobs
Journal:  Curr Urol Rep       Date:  2019-11-16       Impact factor: 3.092

2.  Co-occurring defect analysis: A platform for analyzing birth defect co-occurrence in registries.

Authors:  Renata H Benjamin; Xiao Yu; Maria Luisa Navarro Sanchez; Han Chen; Laura E Mitchell; Peter H Langlois; Mark A Canfield; Michael D Swartz; Angela E Scheuerle; Daryl A Scott; Hope Northrup; Christian P Schaaf; Joseph W Ray; Scott D McLean; Philip J Lupo; A J Agopian
Journal:  Birth Defects Res       Date:  2019-07-16       Impact factor: 2.344

3.  Retrospective Assessment of Cost Savings From Prevention: Folic Acid Fortification and Spina Bifida in the U.S.

Authors:  Scott D Grosse; Robert J Berry; J Mick Tilford; James E Kucik; Norman J Waitzman
Journal:  Am J Prev Med       Date:  2016-01-11       Impact factor: 5.043

4.  Periconceptional folic acid and risk for neural tube defects among higher risk pregnancies.

Authors:  Julie M Petersen; Samantha E Parker; Corey M Benedum; Allen A Mitchell; Sarah C Tinker; Martha M Werler
Journal:  Birth Defects Res       Date:  2019-08-21       Impact factor: 2.661

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.